J 2023

Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2

SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA et. al.

Basic information

Original name

Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2

Authors

SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA, Martin PEC, Olga GOLUBNITSCHAJA, Raghad Khalid AL-ISHAQ, Martin CAPRNDA, Ludovit GASPAR, Robert PROSECKÝ (203 Czech Republic, belonging to the institution), Katarina GAZDIKOVA, Mariusz ADAMEK, Dietrich BUESSELBERG, Peter KRUŽLIAK (703 Slovakia, guarantor, belonging to the institution) and Peter KUBATKA

Edition

European Journal of Pharmacology, AMSTERDAM, Elsevier, 2023, 0014-2999

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.000 in 2022

RIV identification code

RIV/00216224:14110/23:00131597

Organization unit

Faculty of Medicine

UT WoS

001053815500001

Keywords in English

Flavonoids; Cancer cells; Carcinogenesis; Metabolism; Metabolic reprogramming

Tags

International impact, Reviewed
Změněno: 5/9/2023 10:47, Mgr. Tereza Miškechová

Abstract

V originále

Metabolic reprogramming of cancer cells is a common hallmark of malignant transformation. The preference for aerobic glycolysis over oxidative phosphorylation in tumors is a well-studied phenomenon known as the Warburg effect. Importantly, metabolic transformation of cancer cells also involves alterations in signaling cascades contributing to lipid metabolism, amino acid flux and synthesis, and utilization of ketone bodies. Also, redox regulation interacts with metabolic reprogramming during malignant transformation. Flavonoids, widely distributed phytochemicals in plants, exert various beneficial effects on human health through modulating molecular cascades altered in the pathological cancer phenotype. Recent evidence has identified numerous flavonoids as modulators of critical components of cancer metabolism and associated pathways interacting with metabolic cascades such as redox balance. Flavonoids affect lipid metabolism by regulating fatty acid synthase, redox balance by modulating nuclear factor-erythroid factor 2-related factor 2 (Nrf2) activity, or amino acid flux and synthesis by phosphoglycerate mutase 1. Here, we discuss recent preclinical evidence evaluating the impact of flavonoids on cancer metabolism, focusing on lipid and amino acid metabolic cascades, redox balance, and ketone bodies.